COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study
This research output has an Altmetric Attention Score of 154. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2026.
All research outputs
#332,779
of 34,245,017 outputs
Outputs from The Lancet Respiratory Medicine
#270
of 3,323 outputs
Outputs of similar age
#6,939
of 466,040 outputs
Outputs of similar age from The Lancet Respiratory Medicine
#13
of 69 outputs
Altmetric has tracked 34,245,017 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,323 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 73.5. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 466,040 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.
